Her2 drugs

Trastuzumab, was the first HER2-targeted drug for breast cancer. Based on this, two anti-HER2 ADCs have been developed and approved by the FDA for HER2-

If a tumor is HER2-positive, the HER2-targeted therapy drug trastuzumab (Herceptin) is included in the chemotherapy regimen. Sometimes other drugs that target

Approved HER2-Targeted Drugs. HER2-directed therapy is implemented in the management of nearly all stages of HER2-positive invasive breast

HER2-targeted therapies and HER2-positive breast cancer. HER2-positive breast cancers have a lot of a protein called HER2 on the surface of their cells. The HER2 protein is an important driver of cell growth and survival. HER2-targeted therapies are designed to treat HER2-positive breast cancers.

HER2-positive breast cancers have a lot of a protein called HER2 on the surface of their cells. The HER2 protein is an important driver of cell growth and survival. HER2-targeted therapies are used to treat HER2-positive breast cancers. They have no role in the treatment of HER2-negative cancers. Testing for HER2 status

If a tumor is HER2-positive, the HER2-targeted therapy drug trastuzumab (Herceptin) is included in the chemotherapy regimen. Sometimes other drugs that target

HER2-targeted therapies. Drugs to target HER2 were also developed for HER2-positive breast cancer treatment. Called tyrosine kinase inhibitors (TKIs), these

HER2, but it's largely selective and much better for HER2. I was surprised at the survival improvement [between] 3 drugs vs 2 drugs.

The co-expression of endocrine receptors and HER2, albeit associated with resistance to hormonal and anti-HER2 therapy, resulting in worse prognosis, creates an opportunity of combination treatment, consisting of anti-HER2 drugs and ET, in particular when dual HER2-blockade is used.